Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the “CARACAS” study-Reference-Cited by-同舟云学术

Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the “CARACAS” study

Published:2023-03 Issue: Volume:182 Page:87-97
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Prete Alessandra A.^ORCID,Manca Paolo^ORCID,Messina Marco,Formica Vincenzo^ORCID,Frassineti Giovanni L.,Zampino Maria G.,Corsi Domenico C.,Orciuolo Corrado,Prisciandaro Michele,Bergamo Francesca,Angerilli Valentina,Scartozzi Mario,Casagrande Mariaelena,Masi Gianluca^ORCID,Ronzoni Monica,Morano Federica,Vettore Valentina,Salmaso Roberta,Rasola Cosimo,Maddalena Giulia^ORCID,del Bianco Paola,Milione Massimo,Cremolini Chiara,Fassan Matteo^ORCID,Pietrantonio Filippo,Lonardi Sara^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. https://seer.cancer.gov/statfacts/html/anus.html (date of access 25/February/2022).

2. Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines;Park;Clin Infect Dis,2015

3. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal;Serup-Hansen;J Clin Oncol,2014

4. Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal;Ott;Ann Oncol,2017

5. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study;Morris;Lancet Oncol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in gastrointestinal cancers: Spotlight on the pivotal role of currently available biomarkers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Prognostic value of PD-L1 expression in patients with anal cancer: a meta-analysis;Biomarkers in Medicine;2024-04-02

3. Combining chemotherapy and immunotherapy for advanced anal cancer: are we ready?;The Lancet Oncology;2024-04

4. Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances;Molecular Diagnosis & Therapy;2024-01-24

5. Recent Advances in the Management of Anal Cancer;Healthcare;2023-11-21